Prescription Drug, N.B. Reg. 84-170
Section 5
Cite as Prescription Drug, N.B. Reg. 84-170, s. 5 · current to September 15, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
(1) Subject to the Act and this Regulation, every beneficiary is eligible to receive reimbursement or have payment made on his behalf at the rate payable by the programme for or with respect to entitled services received by the beneficiary on and after October 1, 1975, in accordance with the Act and this Regulation.
(2) No beneficiary is eligible to receive reimbursement or have payment made on his or her behalf for the cost of any entitled service in respect of which the beneficiary is eligible to receive reimbursement or have payment made on his or her behalf under any contract or plan of insurance.
(2.1) Repealed: 2010-52
(2.2) Repealed: 2010-52
(3) Repealed: 97-62
(4) When the human growth hormone drug is an entitled service, a beneficiary who is suffering from growth hormone deficiency may receive reimbursement or have payment made on his or her behalf for the drug only if the beneficiary is registered with the department as suffering from this deficiency.
(5) Where the drug Azidothymidine or any antiretroviral agent used only for the treatment of HIV-infected persons is an entitled service, no beneficiary is eligible to receive reimbursement or have payment made on the beneficiary’s behalf for the drug Azidothymidine or any antiretroviral agent used only for the treatment of HIV-infected persons unless that beneficiary is registered with the department as an HIV-infected person and receives the drug from Regional Health Authority 3 / Régie régionale de la santé 3.
(6) Repealed: 90-178
Read the Prescription Drug on the Province's website ↗
Made under Prescription Drug Payment Act, c. P-15.01.